Interaction of an α+-Thalassemia Deletion with Either a Highly Unstable α-Globin Variant (α2, Codon 59, GGC→GAC) or a Nondeletional α-Thalassemia Mutation (AATAA→AATAAG): Comparison of Phenotypes Illustrating “Dominant” α-Thalassemia
- 1 January 1999
- journal article
- case report
- Published by Taylor & Francis in Hemoglobin
- Vol. 23 (4) , 325-337
- https://doi.org/10.3109/03630269909090748
Abstract
Thalassemia syndromes and unstable hemoglobins traditionally represent two phenotypically separate disorders of hemoglobin synthesis. Highly unstable hemoglobin variants, however, often have phenotypic characteristics associated with both ineffective erythropoiesis (thalassemias) and peripheral hemolysis (unstable hemoglobins). Many highly unstable beta chain variants cause a dominant thalassemia-like phenotype, in which simple heterozygotes for such mutations have a clinical expression similar to thalassemia intermedia. The phenotypic expression of highly unstable alpha-globin variants is usually less severe, due mainly to a gene dosage effect, and they are often only characterized on interaction with other alpha-thalassemia mutations, whence they are classified as nondeletional alpha-thalassemia determinants. This study reports the clinical and hematological findings in five cases with rare alpha-thalassemia genotypes: a single patient with the thalassemic alpha2-globin gene codon 59 Gly-->Asp hemoglobin variant in trans to an alpha(+)-thalassemia deletion, and four compound heterozygotes for the nondeletional alpha-thalassemia polyadenylation mutation (alpha2 gene AATAAA-->AATAAG or alpha(T-Saudi)alpha/-alpha) and an alpha(+)-thalassemia deletion. Evaluation of the clinical and hematological features in these two analogous genotypes clearly demonstrates the more severe clinical expression associated with the alpha-thalassemic unstable hemoglobin variant. In addition, the case in this study with the codon 59 alpha chain variant provides a further example illustrating the spectrum of phenotypes associated with the alpha-thalassemic hemoglobinopathies.Keywords
This publication has 25 references indexed in Scilit:
- Erythroid Marrow Activity and Hemoglobin H Levels in Hemoglobin H DiseaseJournal of Pediatric Hematology/Oncology, 1998
- The Thalassemia Repository (Ninth Edition; Part II)Hemoglobin, 1998
- Molecular defects in Hb H hydrops fetalisBritish Journal of Haematology, 1997
- Hb Arta [β45 (CD4) Phe→Cys]: a new unstable haemoglobin with reduced oxygen affinity in trans with β‐thalassaemiaBritish Journal of Haematology, 1995
- Hb adana or α259(E8)Gly→Aspβ2, A severely unstable α1‐globin variant, observed in combination with the ‐(α)20.5 KB α‐thal‐1 deletion in two Turkish patientsAmerican Journal of Hematology, 1993
- Unstable alpha‐chain hemoglobin variants with factitious beta‐thalassemia biosynthetic ratio: Hb questembert (α131[H14] Ser→Pro) and Hb Caen (α132[H15] Val→Gly)American Journal of Hematology, 1993
- DOMINANT β THALASSAEMIA: MOLECULAR BASIS AND PATHOPHYSIOLOGYBritish Journal of Haematology, 1992
- Molecular basis for dominantly inherited inclusion body beta-thalassemia.Proceedings of the National Academy of Sciences, 1990
- CORRELATION OF CLINICAL PHENOTYPE TO GENOTYPE IN HAEMOGLOBIN H DISEASEThe Lancet, 1988
- α-Thalassaemia caused by a polyadenylation signal mutationNature, 1983